New York, USA, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Rhinitis Pipeline Appears Robust With 32+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight DelveInsight's 'Rhinitis ...

Longbio Pharma’s core product LP-003 is a differentiated Anti-IgE monoclonal antibody with an innovative sequence design. It precisely targets the core pathogenesis of allergic diseases, indicated for ...

Glenmark Pharmaceuticals launches RYALTRIS, an innovative nasal spray for moderate to severe allergic rhinitis, in Brazil after ANVISA approval.

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Agreement further expands Aptar Pharma’s leading ...

Ltd. (NYSE: NSRX) (“” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that abstracts supporting NS002, its ...

SAN DIEGO--(BUSINESS WIRE)--Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and ...

Wei-Yu Lin, a pharmaceutical doctor from Taiwan, has suffered from asthma and allergic rhinitis since childhood, having tried various medical treatments without achieving significant results. At one ...

Although biologics can be effective in reducing allergy symptoms, the high cost of these medications must be weighed when determining whether to use them for allergic rhinitis. But these typical ...

Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods CRYSTAL LAKE, ...